(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) jumped 5.6% to $94.29 at 15:42 EST on Monday, after two successive sessions in a row of losses. NASDAQ is falling 1.81% to $13,519.88, after four consecutive sessions in a row of losses. This seems, as yet, an all-around down trend trading session today.
10x Genomics’s last close was $89.29, 57.28% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 1220243 which is 48.91% above its average volume of 819441.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the ongoing quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.00%, a negative 2.67%, and a positive 3.30%, respectively.
10x Genomics’s highest amplitude of average volatility was 5.89% (last week), 3.49% (last month), and 3.30% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $94.29 at 15:42 EST, way below its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s value is way under its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).